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Abstract
Background: Hepatitis B virus infection is an important health problem in the Turkish community in the
Netherlands. To prevent transmission and progression of the disease in this community, increased screening is
necessary. This study aimed to determine 1) the levels of awareness and knowledge regarding hepatitis B,
comparing these in tested and non-tested Turkish-Dutch in Rotterdam; 2) the self-reported hepatitis B test status in
this population, and how this is related to demographic characteristics, knowledge and awareness.
Methods: We conducted a postal survey amongst first and second generation migrants, aged 16 - 40 years.
Results: The response rate was 30.2% (n = 355 respondents). Levels of awareness and knowledge regarding
hepatitis B were low, as the majority of respondents (73%) never thought about the disease and 58% of the
respondents scored 5 or less out of ten knowledge items. Weighted analysis of self-reports showed a test rate of
15%, and a vaccination rate of 3%. Regression analysis showed that having been tested for hepatitis B was related
to being married and higher levels of awareness and knowledge.
Conclusions: This study shows low levels of hepatitis B awareness and knowledge in the Turkish community in
Rotterdam. Self-reported test rates are lower in people who are not currently married, and in those who have low
levels of awareness and knowledge. Especially, knowledge about the consequences of hepatitis B, such as liver
cancer, was lacking. Therefore, a health promotion intervention should foremost raise awareness, and increase
knowledge on the seriousness of this disease.
Background
Hepatitis B virus (HBV) infection is one of the major
infectious diseases in the world [1]. The endemic status
of the Netherlands is classed as low, but population
migration from high or medium endemic countries
affects the HBV prevalence [2,3]. Each year, around
1,800 HBV infections, 79% of which are chronic, are
reported in the Netherlands [4]. Chronic HBV infections
cause 23% of all liver cancers in the Netherlands, and
are an important problem in ethnic minority groups,
such as the Turkish community [5,6]. While this com-
munity represents 8% of the total city population in Rot-
terdam, it accounts for 30% of reported chronic HBV
infections [7]. Seventy percent of reported infections
among Turks involve people aged between 16 and 40.
In this age-category, the mean incidence of reported
HBV infections is 122 per 100,000 Turkish-Dutch indi-
viduals, much higher than the 35 infections per 100,000
persons reported in the total population of Rotterdam
(Municipal Public Health Services Rotterdam-Rijnmond
(MPHS), unpublished data, Rotterdam, 2007). However,
these figures underestimate the population-prevalence:
many chronic HBV-patients do not have disease symp-
toms, and are not reported. Population-based studies
indicate a prevalence of chronic HBV of 0.2% in the
general Dutch population, and a prevalence of 2.6 -
4.8% in the Turkish-Dutch population [6,8-10].
Most reported patients with chronic HBV have
acquired HBV from their mother at birth [4]. Later in
life, however, transmission is mainly through sexual
contact [11].
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and on vaccinating risk groups, such as newborns from
HBV-infected mothers, children with parent(s) from an
HBV-endemic area, and people with high-risk behaviour
[11]. These programmes however, have not contributed
to the health of the general adult Turkish-Dutch popula-
tion, leaving a substantial part of this population both
undetected and unprotected regarding HBV.
In the past decade, treatment possibilities of chronic
HBV have improved [12]. In order to detect individuals
eligible for treatment and to prevent horizontal transmis-
sion in sexually (pre-)active individuals, screening for HBV
should be promoted specifically in the Turkish-Dutch
population. Public health interventions should target those
who are least likely to participate in screening. Studies in
Asian-American migrant groups, have shown that a lower
screening rate is related to demographic factors - such as
younger age, lower level of education, poor language profi-
ciency, lower socio-economic status, and not having a
health insurance - and lower levels of knowledge and
awareness regarding HBV [13-22].
This study is a first step in developing an intervention
aimed at the promotion of HBV-screening in the Turk-
ish-Dutch population in Rotterdam. In order to target
this intervention adequately, the current study aimed to
determine 1) the levels of awareness and knowledge
regarding HBV, comparing these in tested and non-
tested members of the Turkish-Dutch population in
Rotterdam; 2) the self-reported HBV test status in this
population, and how this is related to demographic
characteristics. In the next phase, we will determine cau-
sal relationships between behavioural and cultural deter-
minants and HBV-screening behaviour.
Methods
As a m p l eo f1 1 7 6i n h a b i t a n t so fR o t t e r d a mw a sd r a w n
from the municipal administration. Included were peo-
ple born in Turkey (first-generation migrants (FGM));
and people born in the Netherlands, with FGM parents
(second-generation migrants (SGM)). Stratification was
done on the basis of gender, migrant generation, and
5-year age group to ensure a minimum number of parti-
cipants in each stratum. In order to over-sample strata
in which a lower response was anticipated, we used
response percentages reported for a health survey in the
same population [23].
The questionnaires were translated and back-trans-
lated by two Turkish-Dutch translators. Inconsistencies
in the translation and different understandings of con-
cepts were discussed until consensus was reached
between the translators.
One week after an announcement from the MPHS,
asking for participation in the survey, FGM received a
letter and questionnaire in both Turkish and Dutch
language. SGM received the letter and questionnaire in
Dutch only. Turkish-spoken support in filling out the
questionnaire was available through telephone contact.
Reminder packages consisting of a letter and question-
naire were sent to those who had not responded within
three weeks. One week thereafter, all non-responders
registered in the public telephone register were called
and asked to respond. Furthermore, we stimulated parti-
cipation by giving interviews on local radio stations,
and by organising a lottery of gift vouchers among
respondents.
Data-collection took place from March to May 2008.
The Medical Ethical Review Board of Erasmus MC, Uni-
versity Medical Center Rotterdam, approved this study.
Development of the questionnaire (Additional file 1)
was guided by focus group discussions in the Turkish
community in Rotterdam [24]. The questionnaire
contained the following sections:
Socio-demographic factors were sex, age, first- or sec-
ond-generation migrant status, marital status, country of
birth of partner, level of education (low-medium-high),
socio-economic status (SES) of the residential area (cate-
gorized in low-mid/high SES), income situation, type of
health insurance and Dutch language proficiency and
use. Questions on the history of Hepatitis B testing and
vaccination included test results and the persons’ experi-
ence with HBV in family and friends. Awareness was
measured through four separate items about the fre-
quency of having thought about HBV in the past year.
Answers could be given on a three-point scale ‘never (1)
- sometimes (2) - often (3)’. Knowledge was measured
by ten statements, on which respondents could answer
true, not true, or I don’t know. Six statements on trans-
mission and consequences were derived from a ques-
tionnaire by Taylor et al. [15]. We also formulated two
statements on prevention. As focus group discussions in
this population had indicated confusion in knowledge
about hepatitis A and B, the last two statements
assessed this issue. The total individual knowledge score
could range from 0-10.
We also measured social-cognitive and socio-cultural
determinants of hepatitis B screening but these will be
described in a separate paper.
Because we used stratification in our sampling, we
weighted all demographic characteristics, test rates, and
awareness and knowledge scores by sex, age group and
migrant generation, to be representative for the 16 to 40
year old Turkish-Dutch population in Rotterdam as per
1 January 2008. We compared tested and non-tested
individuals regarding awareness and knowledge by using
the chi-squared statistic. For this analysis, we dichoto-
mized the awareness scores into low level (never
thought about [the item] in the past year) versus high
level (sometimes or often thought about [the item] in
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scores into 1 (correct answer) versus 0 (incorrect
answer/’don’tk n o w ’). We then used logistic regression
analysis, adjusted for the stratification variables sex, age
and migrant generation, to summarize the independent
associations of demographic characteristics with having
been tested for HBV. In the multivariate logistic regres-
sion analysis, we used stepwise backward selection of
the variables which univariately showed a p-value ≤
0.15. Finally, a second regression model was built which
included the levels of awareness and knowledge, next to
the demographic variables. In this multivariate analysis,
we summarized the overall awareness into low (never
thought about any of the awareness items in the past
12 months) versus high (at least thought about one of
the four awareness-items in the past 12 months). We
summarized the overall knowledge into low (0-5 correct
answers) versus high (> 5 correct answers).
Results
The response rate was 30.2% (n = 355). In the past 12
months, 27% of the respondents (n = 97) had thought at
least once about one or more of the four awareness
items (Table 1). This overall level of awareness differed
between tested and non-tested individuals: 42% of tested
people had some awareness, in contrast with 24% in the
non-tested group (p < .01). Proportionately more tested
than non-tested people had thought about the various
awareness questions, except for the question about the
risk of a family member contracting HBV. Both groups
had hardly thought about this risk (10% and 9%, p = .8).
T h ef i r s tt h r e ek n o w l e d g ei t e m sf o c u s s e do nH B V
transmission. The average proportion of respondents
who answered these items correctly was 54% (Table 2).
For the three items, which tested knowledge about the
consequences of HBV, the average proportion was 35%;
for the two items about the prevention of HBV it was
68%. On average, 33% of respondents gave correct
answers to the two statements about the difference
between hepatitis A and B. Overall, the level of knowl-
edge was higher in people who had been tested. The
exceptions were the knowledge about the transmission
of HBV during childbirth, which was about equally
known by tested and non-tested (62% vs. 53%, p = .22),
and the prevention of HBV by screening, which was
known by 84% in both groups (p = .8). The level of
knowledge about hepatitis A and B vaccination was
equal in both groups (64% vs. 52%, p = .14). Fifty eight
percent of the respondents answered less than six items
correctly. There were no significant differences between
men and women regarding awareness and knowledge,
although men tended to be less aware of HBV (p = .08).
Awareness in FGM and SGM was equally low; the
awareness of SGM men younger than 30 being the
poorest. FGM appeared to have less knowledge than
SGM (p = .06), with SGM women (21-30 year) having
the highest level of knowledge. There were no signifi-
cant differences in awareness and knowledge between
the age groups, although the age group 26-30 years had
slightly more knowledge with 55% scoring 6 or more of
the items correctly, compared to 42% in the total of all
age groups.
Univariate logistic regression analysis of the level of
awareness and knowledge with regard to having been
tested for HBV, showed that relatively more people with
some awareness (i.e. those who had at least thought
about one of the four awareness-items in the past year)
had been tested (OR 2.7 (1.5-4.8, p < .001) than people
who had no awareness at all. It also showed that rela-
tively more people with a knowledge-score of at least
6 out of 10, had been tested (OR 3.6 (2.0-6.6), p < .001)
than people with a lower knowledge-score.
Although in the weighted analysis 52 people (14.7%)
reported having been tested for HBV, only 42 of them
reported the test results. In 86% (36/42) no antibodies
against HBV had been detected in the blood. Four peo-
ple reported that the screening had shown the presence
of anti-HBc (antibodies to HBV core antigen), indicating
infection with the virus in the past resulting in immu-
nity. Four out of the 42 people (9.5%) reported to be
carriers of HBV. Regarding vaccination, eleven respon-
dents (11/355, 3%) were sure to have received full vacci-
nation against HBV (i.e. 3 shots); while another
4 1( 1 2 % )h a dn o tr e c e i v e dt h ef u l ls e r i e so rw e r en o t
Table 1 Level of awareness regarding Hepatitis B in the Turkish-Dutch population in Rotterdam (weighted analysis)
total tested non-tested
n = 355 n = 52 n = 303
% % % p-value
Persons who in the past 12 months have at least sometimes thought about
the disease Hepatitis B 20 32 18 0.01
the personal risk in contracting Hepatitis B 17 29 15 < 0.01
the risk of a family member contracting Hepatitis B 9 10 9 0.8
having a test for Hepatitis B 13 24 11 0.02
Overall (% of respondents who have thought about at least one of the four items) 27 42 24 < 0.01
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The majority of respondents had not been vaccinated
(37%) or did not know whether they had been vacci-
nated (48%).
Univariate analysis showed that proportionately more
respondents who knew family members or friends with
HBV had been tested than those who did not (OR 3.4
(1.7 - 6.7), p < .001) (Table 3). In the multivariate model
which included the factors gender, age, migrant genera-
tion, marital status and knowing someone with HBV,
this latter factor remained significantly related to having
been tested (OR 3.4 (1.7 - 6.7), p < .001). When includ-
ing the levels of awareness and knowledge in the multi-
variate analysis, being married (OR 2.4 (1.1 - 5.2), p <
.05), and higher levels of awareness (OR 2.3 (1.3 - 4.3, p
< .01) and knowledge (OR 3.8 (2.0-7.1, p < .001)
remained significantly related to having been tested. In
this second model, knowing someone with HBV was
borderline significantly related to having been tested for
HBV (p = .06).
Discussion and Conclusions
This study shows that the level of awareness regarding
HBV in the Turkish-Dutch population is low. While
H B Vi sas e r i o u sh e a l t hp r o b l e mi nt h i sc o m m u n i t y ,
over 70% of respondents have never thought about it in
the past year. Knowledge about transmission and pre-
vention of HBV is moderate, while there is especially
little knowledge about the serious consequences of
HBV. In this study, low HBV test- and vaccination rates
are reported (15% and 3%, respectively). Test rates are
even lower in people who are not married, or have
lower levels of awareness and knowledge.
This study is the first research into awareness and
knowledge regarding HBV and HBV-test rates in the
Turkish community in the Netherlands, but it also has
some limitations. Firstly, although we tried to stimulate
response in various ways, the response rate was rather
low (30.2%). This may be an indication of a lack of
interest for the subject of hepatitis B which may jeopar-
dize future participation in the intervention. The low
response rate may also cause selection bias. Non-
response analysis shows that non-respondents differed
from respondents only with regard to gender (propor-
tion female was 44% among non-respondents versus
54% among respondents), and not to age, migration
generation and socio-economic status. Furthermore, the
reported percentage of HBV carriers in our study is
9.5%, while we expected this to be between 2.6 - 4.8%
[6,8-10]. This indicates that persons affected by HBV
might have been more willing to respond, and that
actual levels of awareness and knowledge in the popula-
tion might be even lower than presented in this study.
Secondly, information bias might have occurred, as in
our questionnaire we gave away some information about
testing and vaccination. This may have resulted in
Table 2 Proportion of people with correct knowledge about Hepatitis B among the tested and non-tested Turkish-
Dutch population in Rotterdam (weighted analysis)
total tested non-tested
n = 355 n = 52 n = 303
% % % p-value
Transmission
Hepatitis B cannot be spread by someone that looks and feels healthy. 54 68 51 0.03
Hepatitis B can be spread during childbirth. 54 62 53 0.22
Hepatitis B can be spread during sexual intercourse. 53 67 50 0.02
Average proportion for transmission 54 66 51 0.02
Consequences of HBV
People with Hepatitis B can be infected for life. 44 69 39 < 0.001
Hepatitis B can cause liver cancer. 25 43 22 < 0.001
People can die from Hepatitis B. 36 53 34 < 0.01
Average proportion for consequences 35 55 32 < 0.001
Prevention
Infection with Hepatitis B can not be prevented. 52 75 48 < 0.001
By being tested for Hepatitis B, one can find out whether one is infected. 84 84 84 0.8
Average proportion for prevention 68 79 66 0.001
Difference Hepatitis A (HAV) and HBV
Hepatitis A and B are transferred from one person to the other in the same way. 13 20 12 0.15
Vaccination for both Hepatitis A and B are available. 54 64 52 0.14
Average proportion for difference HAV and HBV 33 41 32 0.16
Percentage of respondents with a high score (i.e. 6 or more correct answers) 42 71 37 < 0.001
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Thirdly, self-reports of screening and vaccination may
be affected by inaccurate recall or desirability bias.
Fourthly, we cannot assume causality between the fac-
tors on the one hand and having been tested on the
other, because of the cross-sectional research design.
Last, it is not likely that multiple testing has biased the
conclusions as we found a considerable number of
significant differences between the groups, with p-values
below 0.001.
We found low levels of knowledge regarding the con-
sequences of HBV. Studies in Asian migrants in the
USA found higher levels of HBV knowledge [25]. One
possible explanation is that HBV is an even more preva-
lent health problem in Asian populations, than in the
Turkish population. Another is that knowledge may
Table 3 Hepatitis B test-rates related to demographic factors in the Turkish-Dutch population in Rotterdam, the
Netherlands (n = 355)
total Tested
c crude OR (univariate) p-value adjusted OR (multivariate)
e p-value
n = 355 n = 52
Total 100% 14.7%
Sex female 54% 15% 1.1 (0.6-1.8) 0.8 1.1 (0.6-2.0) 0.7
male 46% 14% ref
Age group 0.13 0.1 (overall)
16-20 19% 11% ref
21-25 16% 12% 1.2 (0.4-3.7) 0.7 1.5 (0.5-5.0) 0.5
26-30 20% 21% 1.9 (0.7-5.1) 0.2 2.3 (0.8-6.7) 0.1
31-35 21% 11% 1.6 (0.6-4.4) 0.3 1.7 (0.6-4.8) 0.36
36-40 25% 21% 2.9 (1.2-7.3) 0.02 3.4 (1.3-7.4) 0.02
Migrant generation
a 1st generation 49% 16% ref
2nd generation 51% 13% 1.2 (0.7-2.1) 0.5 1.4 (0.8-2.5) 0.3
Marital status married/living with partner 59% 19% 1.8 (0.9-3.8)
d 0.10
previously/never married 41% 9% ref
Country of birth of
partner
b
not/low endemic 29% 19% 1.3 (0.6-2.7)
d 0.6
high endemic 71% 17% ref
HBV in family or
friends
yes 15% 36% 3.4 (1.7-6.7)
d < 0.001 3.4 (1.6-6.7) < 0.001
no 85% 11% ref
Educational level 0.23
low 32% 14% 1.1 (0.5-2.4)
d 0.8
medium 42% 13% ref
high 26% 16% 1.9 (0.9-3.8)
d 0.08
SES suburb low SES suburb 63% 15% 1.3 (0.7-2.3)
d 0.4
medium/high SES suburb 37% 15% ref
Income situation 0.3
paid job 66% 13% ref
social security 8% 19% 1.0 (0.4-3.1)
d 0.9
fulltime housework 13% 26% 2.4 (1.0-6.0)
d 0.05
student 14% 10% 0.9 (0.2-3.2)
d 0.9
Health insurance basic health insurance 40% 13% ref
basic + supplementary 60% 16% 1.4 (0.7-2.7)
d 0.3
Dutch language
orientation
(proficiency and
use)
low level 47% 17% ref
high level 53% 13% 1.3 (0.7-2.5)
d 0.5
a 1st generation migrant i.e. person born in Turkey. 2nd generation migrant i.e. person born in the Netherlands, with at least one parent born abroad.
b n = 233
c weighted analysis to correct for the stratification variables sex, age group and migrant generation
d adjusted for the stratification variables sex, age group and migrant generation
e the stratification variables sex, age group and migrant generation were retained in the final model
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country of origin or in the host country [19]. As far as
we know, this has not been the case for Turkish
migrants coming to the Netherlands. These health edu-
cation activities may also have influenced the test rates
amongst Asian migrants in the USA (range 8 - 68%)
[15,16,18,19,25-27], which were considerably higher than
the test rate we found amongst Turkish Dutch (14.7%).
Since 1989, national policy has prescribed HBV-
screening for pregnant women. In our study, about 25%
of the married females reported to have been tested.
This proportion appears to be low in view of the fact
that, based on demographic trend information in
migrant women in the Netherlands, we estimate that in
reality about 50% of all married females may have been
tested during pregnancy [28,29]. This would result in a
total test rate of 22%, instead of the reported 15%. The
women who underreported screening, are likely women
who tested negative for HBV and are susceptible to the
virus. As the aim of our intervention is both detecting
HBV and protecting against HBV, we also target our
intervention to these women in order to provide them
with adequate preventive measures. Last, it is likely that
screened women who appeared to be carriers are aware
of having been tested, and therefore the underreporting
does not affect the carrier rate.
Current screening guidelines also include source and
contact tracing, which means that invitations for HBV-
screening are extended to plausible source(s) and con-
tacts of a notified HBV-carrier. This may explain the
results of the regression analyses, which showed that the
factors ‘being married’ and ‘knowing a family member
or friend with HBV’ were (borderline) related to having
been screened. The first time most of the Turkish-
Dutch women will be tested for HBV is during preg-
nancy; which seldom occurs before marriage [30]. The
fact that knowing someone with HBV is related to pre-
vious HBV-testing has been shown in other studies [16]
as well as in our own. This may be due to HBV-affected
family members or friends who are prompted to be
tested themselves, or to the source and contact tracing.
Several studies found an association between higher
age and having been tested [19,31]. Although in our
study we found a tendency that older people were more
often tested, this relation was not significant. While
other studies also found that the level of education, lan-
guage proficiency, and level of health insurance were
associated with previous testing, our findings did not
confirm this. Almost everyone in our study had a health
insurance, and this factor was not associated with having
been screened. It is suggested that in areas with high
levels of health-care coverage, the influence of being
insured has less effect on actually being screened [26].
This might also be valid for the level of education,
which was high in our study.
This study shows that the Turkish population in Rot-
terdam has low levels of awareness and knowledge
regarding HBV, and low rates of HBV-testing and -vac-
cination. While the national HBV-screening policy in
the Netherlands covers mainly pregnant women and
their contacts, the risk of HBV is present in the whole
Turkish-Dutch population. In order to prevent HBV-
transmission in adults, it would be useful to test people
before they become sexually active. The findings in the
present study show that the development of a health
promotion intervention regarding HBV should raise
awareness about the risk of HBV in this population, and
particularly address the serious consequences of HBV.
Additional material
Additional file 1: Questionnaire on hepatitis B, testing and
vaccination in the Turkish community in Rotterdam. Questionnaire
on hepatitis B, testing and vaccination in the Turkish community in
Rotterdam, including demographic items, questions on awareness and
knowledge, and the history of testing and vaccination.
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